A DirEct to PatieNt Study in Chronic Pain

Launched by BOSTON SCIENTIFIC CORPORATION · Aug 23, 2022

Keywords

ClinConnect Summary

This clinical trial, titled "A DirEct to PatieNt Study in Chronic Pain," is looking to gather information directly from patients about their experiences and results after receiving specific medical treatments for chronic pain. The goal is to understand how well these approved therapies work in real-life settings by collecting feedback and objective measurements from patients who are actively receiving or planning to receive these treatments.

To participate in this study, you need to be at least 22 years old and comfortable reading, writing, and speaking in English. You should be either planning to have or have already had a medical device treatment for chronic pain. If you decide to join, you can expect to share your thoughts and experiences regarding your treatment, helping researchers learn more about its effectiveness. This study is currently recruiting participants, and it's a great opportunity to contribute to improving care for people with chronic pain.

Gender

ALL

Eligibility criteria

• Key Inclusion Criteria:
• • Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting
• • Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening
• • Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English
• Key Exclusion Criteria:
• • Requires a legal representative to sign the ICF ascertained from self-reporting